FR2609397A1 - Use of a substance or composition of carbohydrate nature as active principle of a dermatological and/or cosmetological and/or pharmaceutical and/or cell-stimulating composition, and composition containing such a substance or composition of carbohydrate nature - Google Patents

Use of a substance or composition of carbohydrate nature as active principle of a dermatological and/or cosmetological and/or pharmaceutical and/or cell-stimulating composition, and composition containing such a substance or composition of carbohydrate nature Download PDF

Info

Publication number
FR2609397A1
FR2609397A1 FR8802162A FR8802162A FR2609397A1 FR 2609397 A1 FR2609397 A1 FR 2609397A1 FR 8802162 A FR8802162 A FR 8802162A FR 8802162 A FR8802162 A FR 8802162A FR 2609397 A1 FR2609397 A1 FR 2609397A1
Authority
FR
France
Prior art keywords
composition
substance
carbohydrate
chosen
nature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8802162A
Other languages
French (fr)
Other versions
FR2609397B1 (en
Inventor
Marc Pauly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Health and Care Products France SAS
Original Assignee
Laboratoires Serobiologiques SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Serobiologiques SA filed Critical Laboratoires Serobiologiques SA
Priority to FR8802162A priority Critical patent/FR2609397B1/en
Publication of FR2609397A1 publication Critical patent/FR2609397A1/en
Application granted granted Critical
Publication of FR2609397B1 publication Critical patent/FR2609397B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/606Nucleosides; Nucleotides; Nucleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/731Cellulose; Quaternized cellulose derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/732Starch; Amylose; Amylopectin; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/736Chitin; Chitosan; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/737Galactomannans, e.g. guar; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Abstract

The invention relates to the use of a substance or composition of carbohydrate nature as active principle of a dermatological and/or cosmetic and/or pharmaceutical and/or protective and/or structuring and/or bioenergising composition or composition increasing cell or tissue energy reserves. This substance of carbohydrate nature is preferably chosen from monosaccharide, glycoside and heteroside structures. An improvement in cosmetodynamic activity is obtained.

Description

Utilisation d'une substance ou composition de nature glucidique comme principe actif d'une composition dermatologique et/ou cosmétologique et/ou pharmaceutique et/ou stimulante cellulaire, et composition contenant une telle substance ou composition de nature glucidique.Use of a substance or composition of a carbohydrate nature as active principle of a dermatological and / or cosmetological and / or pharmaceutical and / or cellular stimulant composition, and composition containing such a substance or composition of a carbohydrate nature.

La présente invention concerne essentiellement une utilisation d'une substance, et une composition de nature glucidique comme principe actif d'une composition dermatologique et/ou cosmétologique et/ou pharmaceutique et/ou stimulante cellulaire, et composition contenant une telle substance ou composition de nature glucidique. The present invention essentially relates to a use of a substance, and a composition of a carbohydrate nature as an active principle of a dermatological and / or cosmetic and / or pharmaceutical and / or cellular stimulant composition, and composition containing such a substance or composition of carbohydrate.

Plus particulièrement, l'invention concerne l'utilisation d'une substance ou composition de nature glucidique d'origine naturelle, animale, végétale, micro-organique (bactéries, levures, fungi), extractive ou biotechnologique ou d'origine biosynthétique, comme principe actif d'une composition dermatologique et/ou cosmétologique et/ou pharmaceutique et/ou protectrice ou et/ou structurante et/ou bioénergisante ou accroissante des réserves énergétiques cellulaires, des membranes cellulaires, tissulaires. More particularly, the invention relates to the use of a substance or composition of a carbohydrate nature of natural, animal, plant, micro-organic (bacteria, yeast, fungi), extractive or biotechnological or of biosynthetic origin, as principle. active ingredient of a dermatological and / or cosmetic and / or pharmaceutical and / or protective or and / or structuring and / or bioenergizing or increasing energetic reserve of cellular, cellular, tissue membranes composition.

Selon un mode de réalisation avantageux de l'invention, cette substance ou composition de nature glucidique est présente seule ou en combinaison avec d'autres substances de nature glucidique ou en combinaison avec d'autres principes actifs, notamment de nature protidique, oligo- ou poly-peptidique, aminoacide ou lipidique, cette association permettant ainsi d'améliorer et/ou de compléter leur activité précitée. According to an advantageous embodiment of the invention, this substance or composition of carbohydrate nature is present alone or in combination with other substances of carbohydrate nature or in combination with other active principles, in particular of protein, oligo- or poly-peptide, amino acid or lipid, this association thus making it possible to improve and / or supplement their abovementioned activity.

Selon un mode de réalisation particulier, cette substance ou composition de nature glucidique est incorporée dans des vésicules de type liposomes ou dans des phases lamellaires lipidiques hydratées. According to a particular embodiment, this substance or composition of a carbohydrate nature is incorporated in vesicles of the liposome type or in hydrated lipid lamellar phases.

Cette substance de type glucidique est, selon un mode de réalisation préféré, choisie parmi les structures osiques, osidiques et hétérosidiques.  This carbohydrate type substance is, according to a preferred embodiment, chosen from osic, osidic and heterosidic structures.

Les oses peuvent être définis comme suit o OSES
- Aldoses, notamment choisis parmi le groupe comprenant
D-Glycéraldéhyde, Thréose, Erythrose, Lyxose, Xylose,
Arabinose, Ribose, Talose, Galactose, Idose, Gulose,
Mannose, Glucose, Altrose, Allose
- Cétoses, notamment choisis parmi le groupe comprenant
Dihydroxyacétone, Erythrulose, Xylulose, Ribulose,
Ribose, Tagatose, Sorbose, Fructose, Allulose, ainsi
que leur homologue désoxy tels que désoxyribose
- Glucosamine, Acétylglucosamine.
The dares can be defined as follows o OSES
- Aldoses, in particular chosen from the group comprising
D-Glyceraldehyde, Threose, Erythrose, Lyxose, Xylose,
Arabinose, Ribose, Talose, Galactose, Idose, Gulose,
Mannose, Glucose, Altrose, Allose
- Ketoses, in particular chosen from the group comprising
Dihydroxyacetone, Erythrulose, Xylulose, Ribulose,
Ribose, Tagatose, Sorbose, Fructose, Allulose, as well
that their deoxy counterpart such as deoxyribose
- Glucosamine, Acetylglucosamine.

-Acides uroniques, notamment choisis parmi le groupe
comprenant l'acide D-glucuronique, D-galacturonique,
D-mannuronique
- Oses complexes, notamment choisis parmi le groupe com
prenant l'acide cétodésoxyoctulosonique, l'acide mura
mique, neuraminique.
-Uronic acids, especially chosen from the group
including D-glucuronic acid, D-galacturonic,
D-mannuronic
- Complex bones, in particular chosen from the com group
taking ketodeoxyoctulosonic acid, mura acid
mique, neuramine.

Les osides sont avantageusement choisis parmi
- Les diholosides
Réducteurs comme le lactose, le maltose, le cello
biose, le gentiobiose, le mélibiose,
non réducteurs, tels que le saccharose, le tréhalose
- Les triholosides, tels que le gentianose, le raffi
nose, le mélézitose
- Les polyosides
Ce pourra etre
un homopolyholoside, végétal animal ou micro
organique (bactéries, levures, fungi)
Glucanes (amidon, glycogène, cellulose)
Galactanes (sulfatés/agar-agar, carragénine, ou
non sulfatés)
Mannanes (mucilages)
Fructosanes (inuline)
Arabanes
Xylanes
et leurs dérivés tels que la Chitine, les Chitosans
un hétéropolyholoside
Galactomannane
Hémicellulose
Gommes et mucilages
. un polyuronide
Pectine végétale ou bactérienne
Acide alginique
Gomme arabique
. les mucopolysaccharides acides tels que la
chrondroitine sulfate, le dermatane sulfate,
utilisés libres ou associés à une partie polypepti
dique sous forme de protéoglycannes acides, les kéra
tane-sulfates, l'acide hyaluronique
Acide téichoique.
The osides are advantageously chosen from
- Diholosides
Reducers like lactose, maltose, cello
biosis, gentiobiosis, melibiose,
non-reducing, such as sucrose, trehalose
- Triholosides, such as gentianose, raffi
nose, melezitosis
- Polysaccharides
It could be
a homopolyholoside, animal or micro plant
organic (bacteria, yeast, fungi)
Glucans (starch, glycogen, cellulose)
Galactans (sulfates / agar-agar, carrageenan, or
not sulfated)
Mannans (mucilages)
Fructosanes (inulin)
Arabanes
Xylanes
and their derivatives such as Chitin, Chitosans
a heteropolyholoside
Galactomannan
Hemicellulose
Erasers and mucilages
. a polyuronide
Vegetable or bacterial pectin
Alginic acid
Gum arabic
. acid mucopolysaccharides such as
chrondroitin sulfate, dermatan sulfate,
used free or associated with a polypepti part
dique in the form of acid proteoglycans, kera
tane sulfates, hyaluronic acid
Teichoic acid.

Les hétérosides seront avantageusement choisis parmi
. Hétérosides anthraquinoniques
. Hétérosides hétérocycliques oxygénés coumariniques,
flavoniques, anthocyaniques (famille des Composées)
. les tanins
. les saponosides, en particulier des Liliacées,
Caryophyllacées,
. les conjugués, glucoroniques
les glycolipides
Ces substances glucidiques ou glucides pourront être utilisées seules ou en combinaison et incorporées dans des préparations de type crème, gel, lotion, lait, baume pour former des compositions dermatologiques et/ou cosmétologiques et/ou pharmaceutiques à visée renforçatrice du potentiel bioénergétique cellulaire ou tissulaire à visée, structuratrice, ou à visée ou tissulaire.
The heterosides will advantageously be chosen from
. Anthraquinone heterosides
. Coumarinated heterocyclic oxygen heterosides,
flavonics, anthocyanins (family of Compounds)
. tannins
. saponosides, in particular Liliaceae,
Caryophyllaceae,
. conjugates, glucoronic
glycolipids
These carbohydrate or carbohydrate substances may be used alone or in combination and incorporated into preparations of the cream, gel, lotion, milk or balm type to form dermatological and / or cosmetological and / or pharmaceutical compositions for reinforcing the bioenergetic cell or tissue potential. aiming, structuring, or aiming or tissue.

Ces compositions pourront agir dans le sens d'une amélioration du confort cutané, grâce à leur effet hydratant, adoucissant, assouplissant, énergisant.  These compositions can act in the direction of improving skin comfort, thanks to their hydrating, softening, softening and energizing effect.

Une autre activité présentée par ces glucides consiste en une action ' astringente, hémostatique, tonifiante veineuse, une action anti-inflammatoire, protectrice cellulaire ou tissulaire. Another activity presented by these carbohydrates consists of an astringent, haemostatic, venous toning action, an anti-inflammatory action, protective cell or tissue.

L'utilisation d'oses simples ou de polyosides leur confère une action plus spécifiquement hydratante, nourrissante. The use of simple oses or polysaccharides gives them a more specifically hydrating, nourishing action.

On peut leur adjoindre des mucilages pour leur donner une action adoucissante. We can add mucilage to them to give them a softening action.

Par ailleurs, l'utilisation de glucosides végétaux est particulièrement intéressante en leur conférant une action antiinflammatoire, astringente, cicatrisante, tonifiante veineuse ou photoprotectrice. Les glucosides végétaux sont avantageusement choisis parmi les tanins des Conifères, des Cupulifères, des
Ericacées, des Labiées, des Légumineuses, des Myrtacées, des
Polygonacées, des Rosacées, des Rubiacées, des hétérosides divers, des flavonoides des Polygonacées, des Rutacées, des Légumineuses, des Ombellifères ou des Composées.
In addition, the use of vegetable glucosides is particularly advantageous by conferring on them an anti-inflammatory, astringent, healing, venous or photoprotective action. The plant glucosides are advantageously chosen from the tannins of conifers, cupulifers,
Ericaceae, Labiatae, Legumes, Myrtaceae,
Polygonaceae, Rosaceae, Rubiaceae, various heterosides, flavonoids of Polygonaceae, Rutaceae, Legumes, Umbelliferae or Compositae.

Un couplage des différentes substances de type glucidique permet d'obtenir une action cosméto-dynamique supérieure. A coupling of the various carbohydrate-type substances makes it possible to obtain a superior cosmetic-dynamic action.

La présente invention couvre également une composition notamment dermatologique et/ou cosmétologique et/ou pharmaceutique et/ou protectrice cellulaire, caractérisée en ce qu'elle contient au moins une substance ou composition de nature glucidique telle que ci-dessus définie. La proportion de la substance de nature glucidique est de préférence de 0,01 à 20 % en poids par rapport au poids total de la composition. The present invention also covers a composition, in particular a dermatological and / or cosmetic and / or pharmaceutical and / or cellular protective composition, characterized in that it contains at least one substance or composition of carbohydrate nature as defined above. The proportion of the substance of a carbohydrate nature is preferably from 0.01 to 20% by weight relative to the total weight of the composition.

Selon un mode de réalisation particulièrement intéressant, la substance de nature glucidique'précitée est incorporée dans des vésicules de type liposomes ou dans des phases lamellaires lipidiques hydratées, notamment à une proportion sensiblement égale en poids des vésicules ou des phases lamellaires lipidiques par rapport à la phase aqueuse. Cette composition peut être sous forme de crème, de gel, de lotion. According to a particularly advantageous embodiment, the substance of the above-mentioned carbohydrate nature is incorporated in vesicles of the liposome type or in hydrated lipid lamellar phases, in particular at a proportion substantially equal by weight of the vesicles or lipid lamellar phases relative to the aqueous phase. This composition can be in the form of a cream, gel, lotion.

Une combinaison particulièrement intéressante de glucides est la combinaison saccharose, dextrose, fructose.  A particularly interesting combination of carbohydrates is the combination of sucrose, dextrose, fructose.

D'autres buts, caractéristiques et avantages déterminants de l'invention apparaitront clairement à la lumiere de la description explicative qui va suivre faite en référence à divers exemples de compositions dermatologiques et/ou cosmétologiques et/ou pharmaceutiques et/ou protectrice cellulaire, données simplement à titre d'illustration et qui ne sauraient donc en aucune façon limiter la portée de l'invention. Dans les exemples, tous les pourcentages sont donnés en poids, sauf indication contraire. Other goals, characteristics and decisive advantages of the invention will appear clearly in the light of the explanatory description which will follow made with reference to various examples of dermatological and / or cosmetological and / or pharmaceutical and / or cellular protective compositions, given simply by way of illustration and which therefore cannot in any way limit the scope of the invention. In the examples, all the percentages are given by weight, unless otherwise indicated.

Dans chaque cas, les phases A et B, préalablement chauffées à environ 800C, sont mélangées et émulsionnées puis refroidies. In each case, phases A and B, previously heated to around 800C, are mixed and emulsified and then cooled.

Enfin, s'il y a lieu les phases restantes sont ajoutées. Finally, if necessary, the remaining phases are added.

EXEMPLE 1 : Crème à visée hydratante et nourrissante
Phase A : PROPYLENE GLYCOL 5,00
PEG-100 3,00
SACCHAROSE 2,00
DEXTROSE 1,00
FRUCTOSE 2,50
CHONDROITINE SULFATE 0,50
METHYLPARABEN 0,50
EAU DISTILLEE 66,50
Phase B : HUILE de PARAFFINE 11,00
GLYCERYL STEARATE 5,00
LANOLINE LIQUIDE 3,00
Le mélange de ces constituants se fait de la manière habituelle.
EXAMPLE 1 Cream with Hydrating and Nourishing Aim
Phase A: PROPYLENE GLYCOL 5.00
PEG-100 3.00
SACCHAROSE 2.00
DEXTROSE 1.00
FRUCTOSE 2.50
CHONDROITINE SULFATE 0.50
METHYLPARABEN 0.50
DISTILLED WATER 66.50
Phase B: PARAFFIN OIL 11.00
GLYCERYL STEARATE 5.00
LIOLID LANOLIN 3.00
The mixing of these constituents is carried out in the usual manner.

EXEMPLE 2 : Gel pour le visage
Phase A : GLYCOGENE 0,15
MANNITOL 0,50
EXTRAIT de COMPOSEES 1,00
SORBITOL 0,30
CONSERVATEUR 0,20
EAU DISTILLEE 82,35
GLYCERINE 2,00
* PEG 1500 8,00
Phase B : CARPOBOL R 5,00
TRIETHANOLAMINE 0,50 * PEG = Polyéthylèneglycol
De manière classique, sous agitation, on ajoute tous les composants dans l'eau (à l'exception du carbopoR puis on ajoute le carbopolR pour R pour gélifier la solution.
EXAMPLE 2 Face gel
Phase A: GLYCOGENE 0.15
MANNITOL 0.50
COMPOUND EXTRACT 1.00
SORBITOL 0.30
CONSERVATIVE 0.20
DISTILLED WATER 82.35
GLYCERINE 2.00
* PEG 1500 8.00
Phase B: CARPOBOL R 5.00
TRIETHANOLAMINE 0.50 * PEG = Polyethylene glycol
Conventionally, with stirring, all the components are added in water (with the exception of carbopoR and then carbopolR for R is added to gel the solution.

EXEMPLE 3 : Lotion apaisante
Phase A : EXTRAITS de COMPOSEES 2,50
EXTRAIT de LABIEES 1,00
EXTRAIT de ROSACEES 1,00
GOMME GUAR 1,00
METHYLPARABEN 0,30
GLYCERINE 2,50
EAU DISTILLEE 91,55
Phase C : PARFUM 0,15
EXEMPLE 4 : Crème nourrissante
Phase A : SACCHAROSE 2,50
DEXTROSE 1,80
FRUCTOSE 0,80
CHRONDROITINE SULFATE 0,01
METHYLPARABEN 0,20
EAU DISTILLEE 69,34
Phase B : CHOLESTEROL 0,50
TWEEN 60 1,50
MYRISTATE d'ISOPROPYLE 5,00
SPAN 40 2,20
VASELINE 6,00
LANOLINE 10,00
Phase C : PARFUM 0,15
EXEMPLE 5 : Crème hydratante
Phase A : GLYCOGENE 0,05
MANNITOL 0,20
METHYLPARABEN 0,10
PROPYLENE GLYCOL 2,50
EAU DISTILLEE 69,50
PEG 100 5,00
Phase B : CHOLESTEROL 0,50
STEARATE de GLYCEROL AE 5,00
HUILE de VASELINE 2,00
MYRISTATE d'ISOPROPYLE 15,00
Phase C :PARFUM 0,15
On pourra leur associer d'autres principes actifs, de nature protidique, polypeptidique, oligopeptidique, ou amino-acide à des doses de 0,01 à 50 %, ce qui complétera leur activité cosméto dynamique.
EXAMPLE 3 Soothing Lotion
Phase A: EXTRACTS OF COMPOUNDS 2.50
LABIE EXTRACT 1.00
EXTRACT OF ROSACEOUS 1.00
GUAR GUM 1.00
METHYLPARABEN 0.30
GLYCERINE 2.50
DISTILLED WATER 91.55
Phase C: PERFUME 0.15
EXAMPLE 4 Nourishing Cream
Phase A: SACCHAROSE 2.50
DEXTROSE 1.80
FRUCTOSE 0.80
CHRONDROITINE SULFATE 0.01
METHYLPARABEN 0.20
DISTILLED WATER 69.34
Phase B: CHOLESTEROL 0.50
TWEEN 60 1.50
ISOPROPYLE MYRISTATE 5.00
SPAN 40 2.20
VASELINE 6.00
LANOLINE 10.00
Phase C: PERFUME 0.15
EXAMPLE 5 Hydrating cream
Phase A: GLYCOGENE 0.05
MANNITOL 0.20
METHYLPARABEN 0.10
PROPYLENE GLYCOL 2.50
DISTILLED WATER 69.50
PEG 100 5.00
Phase B: CHOLESTEROL 0.50
GLYCEROL AE STEARATE 5.00
VASELIN OIL 2.00
ISOPROPYLE MYRISTATE 15.00
Phase C: PERFUME 0.15
We can associate them with other active principles, of a protein, polypeptide, oligopeptide or amino acid nature in doses of 0.01 to 50%, which will complete their cosmetic dynamic activity.

Par exemple, dans le domaine de la cicatrisation, l'adjonction de facteurs nutritifs aura un effet bénéfique. For example, in the area of wound healing, the addition of nutritional factors will have a beneficial effect.

EXEMPLE 6 : Crème régénératrice
Phase A : COLLAGENE 5,00
GLUCOSE 5,00
ADN 0,20
L-LYSINE 0,10
L-ALANINE 2,55
GALACTOSE 1,50
METHYLPARABEN 0,15
EAU DISTILLEE 47,85
Phase B : BRIJ 58 2,00
(polyéthylène glycol cetyléther)
HUILE de PARAFFINE 5,00
GLYCERINE 10,00
SPAN 60 2,50
PEG STEARATE 5,00
MIGLYOL 892 8,00
VASELINE 5,00
Phase C : PARFUM 0,15
EXEMPLE 7 : Crème hydratante, nourrissante, antiinflammatoire
Phase A : D-GLUCOSAMINE 0,25
ACIDE GLUTAMIQUE 0,10
D-GLUCOSE 1,00
GLYCOGENE 1,50
EXTRAIT de RUTACEES 1,00
METHYLPARABEN 0,20
EAU DISTILLEE 64,30
Phase B : CIRE de CARNAUBA 3,50
LANOLINE 15,00
MYRISTATE d'ISOPROPYLE 10,00
ARLACEL C 3,00
Phase C : PARFUM 0,15
EXEMPLE 8 : Creme adoucissante
Phase A :L-LYSINE 0,30
L-CYSTEINE 0,25
EXTRAIT de COMPOSEES 2,00
METHYLPARABEN 0,30
GOMME ADRAGANTE 1,00
PECTINE 2,00
EAU DISTILLEE 74,95
PROPYLENE GLYCOL 5,00
Phase B : HUILE de PARAFFINE 10,00
STEARATE de GLYCEROL A.E. 2,00
LANOLINE LIQUIDE 2,00
Phase C : PARFUM 0,20
EXEMPLE 9 : Gel réparateur
Phase A : ACIDE HYALURONIQUE 0,50
N-ACETYL GLUCOSAMINE 1,00
MUCILAGE 1,00
CHONDROITINE SULFATE 0,50
COLLAGENE 1,00
ELASTINE 0,50
METHYLPARABEN 0,30
EAU DISTILLEE 84,00
Phase C : CARBOPOL 10,zoo
TRIETHANOLAMINE 1,00
Phase D : PARFUM 0,20
EXEMPLE 10 : Crème hydratante
Phase A : SACCHAROSE 2,00
DEXTROSE 3,00
OH-PROLINE 0,50
L-ALANINE 0,50
PROPYLENE GLYCOL 2,50
METHYLPARABEN 0,20
EAU DISTILLEE 62,15
Phase B : CIRE de CARNAUBA 2,00
MYRISTATE d'ISOPROPYLE 25,00
HUILE de PARAFFINE 2,00
Phase C :PARFUM 0,15
Ces principes actifs utilisés, seuls ou en combinaison, pourront être présentés de façon avantageuse sous forme liposomée, selon la technique suivante
Les principes actifs sont préparés sous forme d'une solution aqueuse. La membrane des liposomes sera constituée de
- phospholipides, d'origine naturelle ou synthétique
- phospholipides associés à des glycérides
- cholestérol, naturel
-'phospholipides associés à des glycolipides
- lipoprotéines associées à des . cérébrosides
. sphinogolipides
. céphalines
. phospho-amino-lipides
. cérébroglucosides
gangliosides
Ces deux composants sont tout d'abord dissous dans un solvant volatile, variant selon le type de phospholipides choisis, par exemple le chloroforme, le méthanol.
EXAMPLE 6 Regenerating Cream
Phase A: COLLAGENE 5.00
GLUCOSE 5.00
DNA 0.20
L-LYSINE 0.10
L-ALANINE 2.55
GALACTOSE 1.50
METHYLPARABEN 0.15
DISTILLED WATER 47.85
Phase B: BRIJ 58 2.00
(polyethylene glycol cetyl ether)
PARAFFIN OIL 5.00
GLYCERINE 10.00
SPAN 60 2.50
PEG STEARATE 5.00
MIGLYOL 892 8.00
VASELINE 5.00
Phase C: PERFUME 0.15
EXAMPLE 7 Hydrating, nourishing, anti-inflammatory cream
Phase A: D-GLUCOSAMINE 0.25
GLUTAMIC ACID 0.10
D-GLUCOSE 1.00
GLYCOGENE 1.50
EXTRACT OF RUTACEES 1.00
METHYLPARABEN 0.20
DISTILLED WATER 64.30
Phase B: CARNAUBA WAX 3.50
LANOLINE 15.00
ISOPROPYLE MYRISTATE 10.00
ARLACEL C 3.00
Phase C: PERFUME 0.15
EXAMPLE 8 Softening cream
Phase A: L-LYSINE 0.30
L-CYSTEINE 0.25
COMPOUND EXTRACT 2.00
METHYLPARABEN 0.30
ADRAGANANT ERASER 1.00
PECTIN 2,00
DISTILLED WATER 74.95
PROPYLENE GLYCOL 5.00
Phase B: PARAFFIN OIL 10.00
GLARCEROL AE STEARATE 2.00
LIOLID LANOLIN 2.00
Phase C: PERFUME 0.20
EXAMPLE 9 Repairing gel
Phase A: HYALURONIC ACID 0.50
N-ACETYL GLUCOSAMINE 1.00
MUCILAGE 1.00
CHONDROITINE SULFATE 0.50
COLLAGEN 1.00
ELASTINE 0.50
METHYLPARABEN 0.30
DISTILLED WATER 84.00
Phase C: CARBOPOL 10, zoo
TRIETHANOLAMINE 1.00
Phase D: PERFUME 0.20
EXAMPLE 10 Hydrating Cream
Phase A: SUCROSE 2.00
DEXTROSE 3.00
OH-PROLINE 0.50
L-ALANINE 0.50
PROPYLENE GLYCOL 2.50
METHYLPARABEN 0.20
DISTILLED WATER 62.15
Phase B: CARNAUBA WAX 2.00
ISOPROPYLE MYRISTATE 25.00
PARAFFIN OIL 2.00
Phase C: PERFUME 0.15
These active ingredients used, alone or in combination, can be advantageously presented in liposomal form, according to the following technique
The active ingredients are prepared in the form of an aqueous solution. The liposome membrane will consist of
- phospholipids, of natural or synthetic origin
- phospholipids associated with glycerides
- cholesterol, natural
-'phospholipids associated with glycolipids
- lipoproteins associated with. cerebrosides
. sphinogolipids
. cephalins
. phospho-amino lipids
. cerebroglucosides
gangliosides
These two components are first dissolved in a volatile solvent, varying according to the type of phospholipids chosen, for example chloroform, methanol.

Le mélange est placé dans un ballon puis évaporé sous pression réduite dans un évaporateur rotatif, jusqu'à formation d'un film sur les parois du ballon. The mixture is placed in a flask and then evaporated under reduced pressure in a rotary evaporator, until a film is formed on the walls of the flask.

Puis, on ajoute, sous agitation constante, la solution aqueuse de principes actifs à encapsuler. Then, with constant stirring, the aqueous solution of active ingredients to be encapsulated is added.

La suspension obtenue est fractionnée aux ultra-sons sous forme de microglobules ou microsphérules. The suspension obtained is fractionated with ultrasound in the form of microglobules or microspherules.

On obtient ainsi une suspension de liposomes actifs. A suspension of active liposomes is thus obtained.

L'encapsulation des actifs entraîne une optimisation de leur activité cosméto dynamique. The encapsulation of the active ingredients leads to an optimization of their cosmetic-dynamic activity.

EXEMPLE 11
- Phase phospholipidique
PHOSPHOLIPIDES 90,00
CHOLESTEROL 10,00
- Phase aqueuse active
SACCHAROSE 2,50
DEXTROSE 1,80
FRUCTOSE 0,80
CHONDROITINE SULFATE 0,01
METHYLPARABEN 0,20
EAU DISTILLEE qsp 100,00
La préparation se fera selon la technique ci-dessus décrite.
EXAMPLE 11
- Phospholipid phase
PHOSPHOLIPIDS 90.00
CHOLESTEROL 10.00
- Active aqueous phase
SACCHAROSE 2.50
DEXTROSE 1.80
FRUCTOSE 0.80
CHONDROITINE SULFATE 0.01
METHYLPARABEN 0.20
DISTILLED WATER qs 100.00
The preparation will be done according to the technique described above.

EXEMPLE 12
- Phase phospholipidique
PHOSPHOLIPIDES 90,00
CHOLESTEROL 10,00
- Phase aqueuse active
GLYCOGENE 6,00
MANNITOL 5,00
METHYLPARABEN 0,20
EAU DISTILLEE qsp 100,00
La préparation se fera selon la technique ci-dessus decrite.
EXAMPLE 12
- Phospholipid phase
PHOSPHOLIPIDS 90.00
CHOLESTEROL 10.00
- Active aqueous phase
GLYCOGENE 6.00
MANNITOL 5.00
METHYLPARABEN 0.20
DISTILLED WATER qs 100.00
The preparation will be done according to the technique described above.

EXEMPLE 13
- Phase phospholipidique
PHOSPHOLIPIDES 90,00
CHOLESTEROL 10,00
- Phase aqueuse active
SACCHAROSE 2,00
DEXTROSE 3,00
OH-PROLINE 0,50
L-ALANINE 0,50
METHYLPARABEN 0,20
EAU DISTILLEE qsp 100,00
La préparation se fera selon la technique ci-dessus exposée.
EXAMPLE 13
- Phospholipid phase
PHOSPHOLIPIDS 90.00
CHOLESTEROL 10.00
- Active aqueous phase
SACCHAROSE 2.00
DEXTROSE 3.00
OH-PROLINE 0.50
L-ALANINE 0.50
METHYLPARABEN 0.20
DISTILLED WATER qs 100.00
The preparation will be done according to the technique described above.

EXEMPLE 14
- Phase lipidique
GLYCOSPHINGOLIPIDES 100
- Phase aqueuse active
D-GLUCOSAMINE 0,25
L-ARGININE CHLORHYDRATE 0,10
D-GLUCOSE 1,00
GLYCOGENE 1,50
EXTRAIT de RUTACEES + CARYOPHYLACEES 1,00
METHYLPARABEN 0,20
EAU DISTILLEE qsp 100,00 même préparation qu'aux exemples 11 à 13.
EXAMPLE 14
- Lipid phase
GLYCOSPHINGOLIPIDS 100
- Active aqueous phase
D-GLUCOSAMINE 0.25
L-ARGININE HYDROCHLORIDE 0.10
D-GLUCOSE 1.00
GLYCOGENE 1.50
EXTRACT OF RUTACEOUS + CARYOPHYLACEOUS 1.00
METHYLPARABEN 0.20
DISTILLED WATER qs 100.00 same preparation as in examples 11 to 13.

EXEMPLE 15
- Phase phospholipidique
PHOSPHOLIPIDES 90
CHOLESTEROL 10
- Phase aqueuse active
COLLAGENE 5,00
GLUCOSE 5,00
ADN 0,10
L-ALANINE 0,10
GALACTOSE 1,50
METHYLPARABEN 0,20
EAU DISTILLEE qsp 100,00 même préparation qu'aux exemples 11 à 13.
EXAMPLE 15
- Phospholipid phase
PHOSPHOLIPIDS 90
CHOLESTEROL 10
- Active aqueous phase
COLLAGEN 5.00
GLUCOSE 5.00
DNA 0.10
L-ALANINE 0.10
GALACTOSE 1.50
METHYLPARABEN 0.20
DISTILLED WATER qs 100.00 same preparation as in examples 11 to 13.

EXEMPLE 16
- Phase phospholipidique
PHOSPHOLIPIDES 90
CHOLESTEROL 10
- Phase aqueuse active
ACIDES AMINES PLASMATIQUES 1,00
SACCHAROSE 2,50
GOMME GUAR 1,00
EXTRAIT de LABIEES 1,00
EXTRAIT de ROSACEES 1,00
METHYLPARABEN 0,20
EAU DISTILLE qsp 100,00 même préparation qu'aux exemples 11 à 15.
EXAMPLE 16
- Phospholipid phase
PHOSPHOLIPIDS 90
CHOLESTEROL 10
- Active aqueous phase
PLASMATIC AMINO ACIDS 1.00
SACCHAROSE 2.50
GUAR GUM 1.00
LABIE EXTRACT 1.00
EXTRACT OF ROSACEOUS 1.00
METHYLPARABEN 0.20
DISTILLED WATER qs 100.00 same preparation as in examples 11 to 15.

EXEMPLE 17
- Phase phospholipidique
PHOSPHOLIPIDES 90
CHOLESTEROL 10
- Phase aqueuse active
POLYPEPTIDES PLASMATIQUES 0,15
RIBOSE 0,50
EXTRAIT de COMPOSEES 1,00
SORBITOL 0,30
METHYLPARABEN 0,20
EAU DISTILLEE qsp 100,00 même préparation qu'aux exemples Il à 16.
EXAMPLE 17
- Phospholipid phase
PHOSPHOLIPIDS 90
CHOLESTEROL 10
- Active aqueous phase
PLASMATIC POLYPEPTIDES 0.15
RIBOSE 0.50
COMPOUND EXTRACT 1.00
SORBITOL 0.30
METHYLPARABEN 0.20
DISTILLED WATER qs 100.00 same preparation as in examples II to 16.

EXEMPLE 18
- Phase phospholipidique
PHOSPHOLIPIDES 90
CHOLESTEROL 10
- Phase aqueuse active
FRUCTOSE 0,25
CHONDROITINE SULFATE 0,50
METHYLPARABEN 0,50
EAU DISTILLEE qsp 100,00 même préparation qu'aux exemples 11 à 17.
EXAMPLE 18
- Phospholipid phase
PHOSPHOLIPIDS 90
CHOLESTEROL 10
- Active aqueous phase
FRUCTOSE 0.25
CHONDROITINE SULFATE 0.50
METHYLPARABEN 0.50
DISTILLED WATER qs 100.00 same preparation as in examples 11 to 17.

On peut constater des exemples qui précèdent 11 à 18 que, lorsque les principes actifs sont présents sous forme liposomée, ils pourront être incorporés dans diverses préparations cosmétiques du type gel, crème, lotion, dont la phase active est environ égale en poids à la phase phospholipidique. It can be seen from the examples above 11 to 18 that, when the active principles are present in liposomal form, they may be incorporated into various cosmetic preparations of the gel, cream, lotion type, the active phase of which is approximately equal in weight to the phase phospholipid.

Grâce à l'incorporation sous forme liposomée, on obtient une supériorité de l'activité que ce soit concernant l'activité hydratante, assouplissante, adoucissante, énergisante, anti-inflammatoire, cicatrisante, astringente, hémostatique, tonifiante veineuse, stimulante, protectrice cellulaire. Thanks to the incorporation in liposomal form, one obtains a superiority of the activity whether it is concerning the hydrating, softening, softening, energizing, anti-inflammatory, healing, astringent, hemostatic, venous toning, stimulating, cell protective activity.

Naturellement, l'invention comprend tous les moyens constituant des équivalents techniques des moyens décrits ainsi que leurs diverses combinaisons.  Naturally, the invention includes all the means constituting technical equivalents of the means described as well as their various combinations.

Claims (12)

REVENDICATIONS 1. Utilisation d'une substance ou composition de nature glucidique d'origine naturelle, animale, végétale, micro-organique (bactéries, levures, fungi), extractive ou biotechnologique ou d'origine synthétique, comme principe actif d'une composition dermatologique et/ou cosmétologique et/ou pharmaceutique et/ou protectrice ou bioénergisante, ou accroissante des réserves énergétiques des cellules vivantes, des tissus vivants ou des membranes cellulaires. 1. Use of a substance or composition of a carbohydrate nature of natural, animal, vegetable, micro-organic origin (bacteria, yeasts, fungi), extractive or biotechnological or of synthetic origin, as active ingredient of a dermatological composition and / or cosmetological and / or pharmaceutical and / or protective or bioenergizing, or increasing the energy reserves of living cells, living tissues or cell membranes. 2. Utilisation selon la revendication 1, caractérisée en ce que la substance ou composition est présente seule ou en combinaison avec d'autres substances de nature glucidique ou en combinaison avec d'autres principes actifs, notamment de nature protidique, oligo- ou poly-peptidique, aminoacide ou lipidique, cette combinaison permettant ainsi d'améliorer et/ou de compléter leur activité précitée. 2. Use according to claim 1, characterized in that the substance or composition is present alone or in combination with other substances of carbohydrate nature or in combination with other active ingredients, in particular of protein, oligo- or poly- peptide, amino acid or lipid, this combination thus making it possible to improve and / or supplement their abovementioned activity. 3. Utilisation selon la revendication 1 ou 2, caractérisée en ce que la substance ou composition de nature glucidique est incorporée dans des vésicules type liposomes ou dans des phases lamellaires lipidiques hydratées. 3. Use according to claim 1 or 2, characterized in that the substance or composition of carbohydrate nature is incorporated in vesicles of liposome type or in hydrated lipid lamellar phases. 4. Utilisation selon l'une des revendications 1 à 3, caractérisée en ce que la substance de type glucidique est choisie parmi les structures osiques, osidiques et hétéro-osidiques. 4. Use according to one of claims 1 to 3, characterized in that the carbohydrate type substance is chosen from osic, osidic and hetero-oidic structures. 5. Utilisation selon la revendication 4, caractérisée en ce que les oses sont choisis parmi 5. Use according to claim 4, characterized in that the dares are chosen from - Aldoses, notamment choisis parmi le groupe comprenant - Aldoses, in particular chosen from the group comprising D-Glycéraldéhyde, Thréose, Erythrose, Lyxose, Xylose, D-Glyceraldehyde, Threose, Erythrose, Lyxose, Xylose, Arabinose, Ribose, Talose, Galactose, Idose, Gulose, Arabinose, Ribose, Talose, Galactose, Idose, Gulose, Mannose, Glucose, Altrose, Allose Mannose, Glucose, Altrose, Allose - Cétoses, notamment choisis parmi le groupe comprenant - Ketoses, in particular chosen from the group comprising Dihydroxyacétone, Erythrulose, Xylulose, Ribulose, Dihydroxyacetone, Erythrulose, Xylulose, Ribulose, Tagatose, Sorbose, Fructose, Allulose, ainsi que leur Tagatose, Sorbose, Fructose, Allulose, as well as their homologue désoxy tels que désoxyribose deoxy counterpart such as deoxyribose - Glucosamine, Acétylglucosamine  - Glucosamine, Acetylglucosamine - Acides uroniques, notamment choisis parmi le groupe - Uronic acids, in particular chosen from the group comprenant l'acide D-glucuronique, D-galacturonique, including D-glucuronic acid, D-galacturonic, D-mannuronique D-mannuronic - Oses complexes, notamment choisis parmi le groupe com - Complex bones, in particular chosen from the com group prenant l'acide cétodésoxyoctulosonique, l'acide mura taking ketodeoxyoctulosonic acid, mura acid mique, neuraminique. mique, neuramine. 6.Utilisation selon l'une quelconque des revendications 1 à 5, caractérisée en ce que la substance ou composition de type glucidique précitée est utilisée en combinaison deux à deux, trois à trois, etc. 6.Use according to any one of claims 1 to 5, characterized in that the substance or composition of the above-mentioned carbohydrate type is used in pairs, three to three, etc. exemple, Glucocérébrosides ou galactocérébrosides)  example, Glucocerebrosides or galactocerebrosides) . les glycolipides (Glyco et galactolipides par . glycolipids (Glyco and galactolipids by les conjugués glucuroniques glucuronic conjugates ou des Caryophyllacées, or Caryophyllaceae, . les saponosides, en particulier des Liliacées . saponosides, especially Liliaceae . les tanins . tannins flavoniques, anthocyaniques (famille des Composées) flavonics, anthocyanins (family of Compounds) . Hétérosides hétérocycliques oxygénés coumariniques, . Coumarinated heterocyclic oxygen heterosides, . Hétérosides anthraquinoniques . Anthraquinone heterosides - Les hétérosides sont choisis parmi - The heterosides are chosen from acides, les kératane-sulfate, l'acide hyaluronique acids, keratan sulfate, hyaluronic acid polypeptidique sous forme de protéoglycannes polypeptide in the form of proteoglycans utilisés libres ou associés à une partie used free or associated with a game chrondroltine sulfate, le dermatane sulfate,  chrondroltine sulfate, dermatan sulfate, . les mucopolysaccharides acides tels que la . acid mucopolysaccharides such as Gomme arabique Gum arabic Acide alginique Alginic acid Pectine végétale ou bactérienne Vegetable or bacterial pectin . un polyuronide . a polyuronide Gommes et mucilages Erasers and mucilages Galactomannane Hémicellulose  Galactomannan Hemicellulose . un hétéropolyholoside . a heteropolyholoside et leurs dérivés tels que la Chitine, le Chitosan and their derivatives such as Chitin, Chitosan Xylanes Xylanes Arabanes Arabanes Fructosanes (inuline) Fructosanes (inulin) Mannanes (mucilages) Mannans (mucilages) non sulfatés) not sulfated) Galactanes (sulfatés/agar-agar, carragénine, ou Galactans (sulfates / agar-agar, carrageenan, or Glucanes (amidon, glycogène, cellulose) Glucans (starch, glycogen, cellulose) organique (bactéries, levures, fungi) organic (bacteria, yeast, fungi) un homopolyholoside, végétal animal ou micro a homopolyholoside, animal or micro plant - Les polyosides - Polysaccharides nose, le mélézitose nose, melezitosis - Les triholosides, tels que le gentianose, le raffi - Triholosides, such as gentianose, raffi . non réducteurs, tels que le saccharose, le tréhalose . non-reducing, such as sucrose, trehalose biose, le gentiobiose, le mélibiose, biosis, gentiobiosis, melibiose, Réducteurs comme le lactose, le maltose, le cello Reducers like lactose, maltose, cello - Les diholosides - Diholosides - Les osides sont choisis parmi- The osides are chosen from 7. Utilisation selon l'une quelconque des revendications 1 à 6, caractérisée en ce que la substance de nature glucidique précitée est un glucoside végétal, avantageusement un tanin de 7. Use according to any one of claims 1 to 6, characterized in that the substance of the aforementioned glucidic nature is a vegetable glucoside, advantageously a tannin of Conifères, de Cupulifères, d1Ericacées, de Labiées, de Légumineuses, de Myrtacées, de Polygonacées, de Rutacées, de Légumineuses, d'Ombellifères ou de Composées.Conifers, Cupulifers, Ericaceae, Labiatae, Legumes, Myrtaceae, Polygonaceae, Rutaceae, Legumes, Umbelliferae or Compositae. 8. Composition notamment dermatologique et/ou cosmétologique et/ou pharmaceutique, caractérisée en ce qu'elle contient au moins une substance ou composition de nature glucidique telle que définie à l'une quelconque des revendications d'utilisation 1 à 7. 8. Composition, in particular dermatological and / or cosmetic and / or pharmaceutical, characterized in that it contains at least one substance or composition of a carbohydrate nature as defined in any one of claims for use 1 to 7. 9. Composition selon la revendication 8, caractérisée en ce que la proportion de la substance de nature glucidique est de 0,01 à environ 20 % en poids par rapport au poids total de la composition. 9. Composition according to claim 8, characterized in that the proportion of the substance of carbohydrate nature is from 0.01 to about 20% by weight relative to the total weight of the composition. 10. Composition selon une des revendications 8 à 10, caractérisée en ce que la substance de nature glucidique est incor porée dans des vésicules type liposomes ou dans des phases lamellaires lipidiques hydratées, notamment à une proportion sensiblement égale en poids des vésicules ou des phases lamellaires lipidiques par rapport à la phase aqueuse. 10. Composition according to one of claims 8 to 10, characterized in that the substance of carbohydrate nature is incorporated in vesicles of liposome type or in hydrated lipid lamellar phases, in particular at a substantially equal proportion by weight of the vesicles or lamellar phases lipid relative to the aqueous phase. 11. Composition selon l'une des revendications 8 à 10, caractérisée en ce qu'elle se présente sous forme de crème, de gel, de lotion, contenant des liposomes dont les parois sont des phospholipides ou des glygolipides ou une association des deux. 11. Composition according to one of claims 8 to 10, characterized in that it is in the form of a cream, gel, lotion, containing liposomes whose walls are phospholipids or glygolipids or a combination of the two. 12. Composition selon l'une des revendications 8 à 11, caractérisée en ce qu'elle comprend une combinaison de saccharose, de dextrose et de fructose.  12. Composition according to one of claims 8 to 11, characterized in that it comprises a combination of sucrose, dextrose and fructose.
FR8802162A 1988-02-23 1988-02-23 USE OF A CARBOHYDRATE SUBSTANCE OR COMPOSITION AS AN ACTIVE INGREDIENT OF A DERMATOLOGICAL AND / OR COSMETOLOGICAL AND / OR PHARMACEUTICAL AND / OR CELL STIMULANT COMPOSITION, AND COMPOSITION CONTAINING SUCH A CARBON SUBSTANCE OR COMPOSITION Expired - Lifetime FR2609397B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR8802162A FR2609397B1 (en) 1988-02-23 1988-02-23 USE OF A CARBOHYDRATE SUBSTANCE OR COMPOSITION AS AN ACTIVE INGREDIENT OF A DERMATOLOGICAL AND / OR COSMETOLOGICAL AND / OR PHARMACEUTICAL AND / OR CELL STIMULANT COMPOSITION, AND COMPOSITION CONTAINING SUCH A CARBON SUBSTANCE OR COMPOSITION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8802162A FR2609397B1 (en) 1988-02-23 1988-02-23 USE OF A CARBOHYDRATE SUBSTANCE OR COMPOSITION AS AN ACTIVE INGREDIENT OF A DERMATOLOGICAL AND / OR COSMETOLOGICAL AND / OR PHARMACEUTICAL AND / OR CELL STIMULANT COMPOSITION, AND COMPOSITION CONTAINING SUCH A CARBON SUBSTANCE OR COMPOSITION

Publications (2)

Publication Number Publication Date
FR2609397A1 true FR2609397A1 (en) 1988-07-15
FR2609397B1 FR2609397B1 (en) 1991-12-13

Family

ID=9363520

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8802162A Expired - Lifetime FR2609397B1 (en) 1988-02-23 1988-02-23 USE OF A CARBOHYDRATE SUBSTANCE OR COMPOSITION AS AN ACTIVE INGREDIENT OF A DERMATOLOGICAL AND / OR COSMETOLOGICAL AND / OR PHARMACEUTICAL AND / OR CELL STIMULANT COMPOSITION, AND COMPOSITION CONTAINING SUCH A CARBON SUBSTANCE OR COMPOSITION

Country Status (1)

Country Link
FR (1) FR2609397B1 (en)

Cited By (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2639828A1 (en) * 1988-12-01 1990-06-08 Lvmh Rech USE OF KAEMPFEROL AND SOME DERIVATIVES THEREOF FOR THE PREPARATION OF A COSMETIC OR PHARMACEUTICAL COMPOSITION
EP0382210A1 (en) * 1989-02-08 1990-08-16 Unitika Ltd. The use of deacetylated chitin for preparing a medicament for the treatment of inflammatory skin diseases
WO1990011069A1 (en) * 1989-03-20 1990-10-04 Parfums Christian Dior Process for the preparation of a ligand-receptor complex
FR2652742A1 (en) * 1989-10-11 1991-04-12 Vacher Dominique Anallergic cosmetic and dermopharmaceutical compositions
EP0432309A1 (en) * 1989-12-15 1991-06-19 Laevosan-Gesellschaft m.b.H. Sugar derivatives, process for their preparation and their use
EP0500718A1 (en) * 1989-11-09 1992-09-02 Byron A Donzis Insoluble yeast extract.
WO1992015311A1 (en) * 1991-03-01 1992-09-17 Depha Team S.R.L. Dietetic or pharmaceutical compositions for the restoration of adenine nucleotide cell content in skeletal and cardiac muscles
FR2683721A1 (en) * 1991-11-15 1993-05-21 Inocosm Laboratoires POLAR LIPID COMPOSITION FOR VEHICULATING AN ACTIVE AGENT AND / OR PENETRATING IT INTO A TARGET CELL
WO1994002586A2 (en) * 1992-07-24 1994-02-03 Agricultural And Food Research Council Repression of virulent gene expression
WO1995005155A1 (en) * 1993-08-17 1995-02-23 Roc S.A. Use of oligosaccharides for the prevention and treatment of tissue ageing
WO1996023479A2 (en) * 1995-02-03 1996-08-08 Beiersdorf Ag Anti-adhesive active principles
FR2730409A1 (en) * 1995-02-15 1996-08-14 Dior Christian Parfums USE OF GALACTOLIPIDS, IN PARTICULAR GALACTOSYLGLYCERIDES, AND EXTRACTS OF NATURAL ORIGIN CONTAINING THESE PRODUCTS, IN THE COSMETIC, PHARMACEUTICAL AND IN PARTICULAR DERMATOLOGICAL FIELDS
FR2743296A1 (en) * 1996-01-10 1997-07-11 Oreal New cleansing or make-up removal composition
EP0783883A3 (en) * 1996-01-10 1997-08-13 L'oreal Use of polyholosides in cleaning compositions or in make-up removers, and compositions containing the same
EP0693928A4 (en) * 1993-03-31 1998-06-03 Nutramax Lab Inc Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue
EP0852946A2 (en) * 1996-11-29 1998-07-15 Gianfranco De Paoli Ambrosi Composition for cosmetic, pharmaceutical or dietetic use based on an amino-sugar and/or a polyhydroxylic acid
EP0979090A1 (en) * 1997-04-28 2000-02-16 Nutramax Laboratories, Inc. Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine
WO2000054743A1 (en) * 1999-03-12 2000-09-21 Biotec Asa Cosmetic and/or pharmaceutical preparations
EP1075836A2 (en) * 1999-08-09 2001-02-14 Yaizu Suisankagaku Industry Co., Ltd. Skin care of food composition containing N-acetyl-glucosamine
US6271213B1 (en) 1996-12-23 2001-08-07 Nutramax Laboratories, Inc. Aminosugar, glycosaminoglycan, and S-adenosylmethionine composition for the treatment and repair of connective tissue
WO2002076423A2 (en) * 2001-03-22 2002-10-03 The Procter & Gamble Company Skin care compositions containing a sugar amine
DE10126396A1 (en) * 2001-05-31 2002-12-05 Beiersdorf Ag Cosmetic or dermatological preparations containing glucosamine, useful e.g. for treatment, care and prophylaxis of sensitive skin and treatment of inflammatory conditions such as eczema or psoriasis
WO2003092703A1 (en) * 2002-04-30 2003-11-13 Hisamitsu Pharmaceutical Co., Inc. Methods and compositions for inhibition or irritation by disaccharide and metal ions
FR2863498A1 (en) * 2003-12-12 2005-06-17 Rocher Yves Biolog Vegetale Use of gum arabic as an active agent in cosmetic and dermatological compositions, useful particularly for treatment and prevention of ageing of the skin
FR2863887A1 (en) * 2003-12-23 2005-06-24 Jean Noel Thorel Well tolerated, biocompatible dermatological and/or cosmetic galenic base, having aqueous phase containing polyols, e.g. sugars and/or sugar alcohols, and preferably lipid phase containing lipo-regulator
FR2883473A1 (en) * 2005-03-25 2006-09-29 Biolog Vegetale Yves Rocher Sa Topical cosmetic composition, useful to induce the tanning of the skin, to fight against cutaneous aging and to protect skin from UV rays, comprises an extract of chicle gum and a vehicle
FR2883750A1 (en) * 2005-04-04 2006-10-06 Virbac Sa Sa Topical composition, useful to inhibit the formation of micro-organisms on the skin of warm-blooded animals with hair, comprises mono or oligosaccharide
EP2073787A2 (en) * 2006-10-05 2009-07-01 Société Industrielle Limousine d'Application Biologique Dite SILAB Use of an active ingredient derived from flax that acts on the papillary dermis, for its anti-ageing action
USRE41278E1 (en) 1999-01-08 2010-04-27 Yu Ruey J N-acetyl aldosamines and related N-acetyl compounds, and their topical use
FR2940610A1 (en) * 2008-12-30 2010-07-02 Oreal ASSOCIATION OF MONOSACCHARIDES WITH C-GLYCOSIDE DERIVATIVES AND ITS USE IN COSMETICS
EP2204162A1 (en) * 2008-12-30 2010-07-07 L'oreal Use of monosaccharides and composition
US9421157B2 (en) 2006-07-03 2016-08-23 L'oreal Use of C-glycoside derivatives as pro-desquamating active agents

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"THE MERCK INDEX - AN ENCYCLOPEDIA OF CHEMICALS, DRUGS, AND BIOLOGICALS", 1983, édition 10, pages 314,315,384,609,1195,1196,1449, Merck & Co., Inc., Rahway, N.J., US *

Cited By (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990006104A1 (en) * 1988-12-01 1990-06-14 Lvmh Recherche Use of kaempferol and certain derivatives thereof for the preparation of a cosmetic or pharmaceutical composition
FR2639828A1 (en) * 1988-12-01 1990-06-08 Lvmh Rech USE OF KAEMPFEROL AND SOME DERIVATIVES THEREOF FOR THE PREPARATION OF A COSMETIC OR PHARMACEUTICAL COMPOSITION
EP0382210A1 (en) * 1989-02-08 1990-08-16 Unitika Ltd. The use of deacetylated chitin for preparing a medicament for the treatment of inflammatory skin diseases
WO1990011069A1 (en) * 1989-03-20 1990-10-04 Parfums Christian Dior Process for the preparation of a ligand-receptor complex
FR2645741A1 (en) * 1989-03-20 1990-10-19 Dior Christian Parfums METHOD FOR FIXING A PRODUCT ON THE MEMBRANE OF A KERATINOCYTE BY MEANS OF A LIGAND-RECEPTOR BOND, PROCESS FOR PREPARING SUCH A PRODUCT, OBTAINED PRODUCT, COSMETIC OR PHARMACEUTICAL COMPOSITION CONTAINING THE SAME, AND PROCESS FOR PREPARING THE SAME
US5286629A (en) * 1989-03-20 1994-02-15 Parfums Christian Dior Method of binding a product to the membrane of a keratinocyte by means of a ligand-receptor bond, method of preparing such a product, product obtained, cosmetic or pharmaceutical composition in which it is present and its method of preparation
FR2652742A1 (en) * 1989-10-11 1991-04-12 Vacher Dominique Anallergic cosmetic and dermopharmaceutical compositions
EP0500718A4 (en) * 1989-11-09 1994-09-14 Byron A Donzis Insoluble yeast extract
EP0500718A1 (en) * 1989-11-09 1992-09-02 Byron A Donzis Insoluble yeast extract.
EP0432309A1 (en) * 1989-12-15 1991-06-19 Laevosan-Gesellschaft m.b.H. Sugar derivatives, process for their preparation and their use
WO1992015311A1 (en) * 1991-03-01 1992-09-17 Depha Team S.R.L. Dietetic or pharmaceutical compositions for the restoration of adenine nucleotide cell content in skeletal and cardiac muscles
FR2683721A1 (en) * 1991-11-15 1993-05-21 Inocosm Laboratoires POLAR LIPID COMPOSITION FOR VEHICULATING AN ACTIVE AGENT AND / OR PENETRATING IT INTO A TARGET CELL
WO1994002586A2 (en) * 1992-07-24 1994-02-03 Agricultural And Food Research Council Repression of virulent gene expression
WO1994002586A3 (en) * 1992-07-24 1994-03-17 Agricultural & Food Res Repression of virulent gene expression
US6492349B1 (en) 1993-03-31 2002-12-10 Nutramax Laboratories, Inc. Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue
EP0693928A4 (en) * 1993-03-31 1998-06-03 Nutramax Lab Inc Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue
WO1995005155A1 (en) * 1993-08-17 1995-02-23 Roc S.A. Use of oligosaccharides for the prevention and treatment of tissue ageing
FR2709061A1 (en) * 1993-08-17 1995-02-24 Robert Ladislas Use of oligosaccharides in the prevention and treatment of tissue aging.
US5910490A (en) * 1993-08-17 1999-06-08 Roc. S.A. Use of oligosaccharides in the prevention and treatment of the aging of tissues
WO1996023479A2 (en) * 1995-02-03 1996-08-08 Beiersdorf Ag Anti-adhesive active principles
WO1996023479A3 (en) * 1995-02-03 1997-03-06 Beiersdorf Ag Anti-adhesive active principles
WO1996025142A1 (en) * 1995-02-15 1996-08-22 Parfums Christian Dior Use of galactosylglycerides and of naturally occurring extracts containing such products in cosmetics, pharmaceutics and particularly dermatology
FR2730409A1 (en) * 1995-02-15 1996-08-14 Dior Christian Parfums USE OF GALACTOLIPIDS, IN PARTICULAR GALACTOSYLGLYCERIDES, AND EXTRACTS OF NATURAL ORIGIN CONTAINING THESE PRODUCTS, IN THE COSMETIC, PHARMACEUTICAL AND IN PARTICULAR DERMATOLOGICAL FIELDS
FR2743296A1 (en) * 1996-01-10 1997-07-11 Oreal New cleansing or make-up removal composition
EP0783883A3 (en) * 1996-01-10 1997-08-13 L'oreal Use of polyholosides in cleaning compositions or in make-up removers, and compositions containing the same
EP0852946A2 (en) * 1996-11-29 1998-07-15 Gianfranco De Paoli Ambrosi Composition for cosmetic, pharmaceutical or dietetic use based on an amino-sugar and/or a polyhydroxylic acid
EP0852946A3 (en) * 1996-11-29 1998-09-16 Gianfranco De Paoli Ambrosi Composition for cosmetic, pharmaceutical or dietetic use based on an amino-sugar and/or a polyhydroxylic acid
US6583123B2 (en) 1996-12-23 2003-06-24 Nutramax Laboratories, Inc. Aminosugar, glycosaminoglycan, and S-adenosylmethionine composition for the treatment and repair of connective tissue
US6255295B1 (en) 1996-12-23 2001-07-03 Nutramax Laboratories, Inc. Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine composition for the protection, treatment, repair, and reduction of inflammation of connective tissue
US6271213B1 (en) 1996-12-23 2001-08-07 Nutramax Laboratories, Inc. Aminosugar, glycosaminoglycan, and S-adenosylmethionine composition for the treatment and repair of connective tissue
EP0979090A1 (en) * 1997-04-28 2000-02-16 Nutramax Laboratories, Inc. Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine
EP1849471A1 (en) * 1997-04-28 2007-10-31 Nutramax Laboratories, Inc. Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and S-adenosylmethionine
EP0979090A4 (en) * 1997-04-28 2000-10-18 Nutramax Lab Inc Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine
USRE44302E1 (en) 1999-01-08 2013-06-18 Ruey J. Yu N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use
USRE41339E1 (en) 1999-01-08 2010-05-18 Tristrata, Inc. N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use
USRE42902E1 (en) 1999-01-08 2011-11-08 Tristrata, Inc. N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use
USRE41278E1 (en) 1999-01-08 2010-04-27 Yu Ruey J N-acetyl aldosamines and related N-acetyl compounds, and their topical use
US6706696B1 (en) 1999-03-12 2004-03-16 Biotec Asa Cosmetic and/or pharmaceutical preparations
WO2000054743A1 (en) * 1999-03-12 2000-09-21 Biotec Asa Cosmetic and/or pharmaceutical preparations
EP1075836A2 (en) * 1999-08-09 2001-02-14 Yaizu Suisankagaku Industry Co., Ltd. Skin care of food composition containing N-acetyl-glucosamine
EP1075836A3 (en) * 1999-08-09 2001-04-25 Yaizu Suisankagaku Industry Co., Ltd. Skin care of food composition containing N-acetyl-glucosamine
WO2002076423A2 (en) * 2001-03-22 2002-10-03 The Procter & Gamble Company Skin care compositions containing a sugar amine
WO2002076423A3 (en) * 2001-03-22 2003-03-13 Procter & Gamble Skin care compositions containing a sugar amine
DE10126396A1 (en) * 2001-05-31 2002-12-05 Beiersdorf Ag Cosmetic or dermatological preparations containing glucosamine, useful e.g. for treatment, care and prophylaxis of sensitive skin and treatment of inflammatory conditions such as eczema or psoriasis
WO2003092703A1 (en) * 2002-04-30 2003-11-13 Hisamitsu Pharmaceutical Co., Inc. Methods and compositions for inhibition or irritation by disaccharide and metal ions
FR2863498A1 (en) * 2003-12-12 2005-06-17 Rocher Yves Biolog Vegetale Use of gum arabic as an active agent in cosmetic and dermatological compositions, useful particularly for treatment and prevention of ageing of the skin
FR2863887A1 (en) * 2003-12-23 2005-06-24 Jean Noel Thorel Well tolerated, biocompatible dermatological and/or cosmetic galenic base, having aqueous phase containing polyols, e.g. sugars and/or sugar alcohols, and preferably lipid phase containing lipo-regulator
FR2883473A1 (en) * 2005-03-25 2006-09-29 Biolog Vegetale Yves Rocher Sa Topical cosmetic composition, useful to induce the tanning of the skin, to fight against cutaneous aging and to protect skin from UV rays, comprises an extract of chicle gum and a vehicle
WO2006106220A3 (en) * 2005-04-04 2007-01-04 Virbac Sa Topical compositions comprising several mono- and/or oligosaccharides for treating skin diseases of warm blood hair coated animals.
WO2006106220A2 (en) * 2005-04-04 2006-10-12 Virbac Sa Topical compositions comprising several mono- and/or oligosaccharides for treating skin diseases of warm blood hair coated animals.
FR2883750A1 (en) * 2005-04-04 2006-10-06 Virbac Sa Sa Topical composition, useful to inhibit the formation of micro-organisms on the skin of warm-blooded animals with hair, comprises mono or oligosaccharide
AU2006231248B2 (en) * 2005-04-04 2012-08-02 Virbac Sa Topical compositions comprising several mono- and/or oligosaccharides for treating skin diseases of warm blood hair coated animals.
US9421157B2 (en) 2006-07-03 2016-08-23 L'oreal Use of C-glycoside derivatives as pro-desquamating active agents
EP2073787A2 (en) * 2006-10-05 2009-07-01 Société Industrielle Limousine d'Application Biologique Dite SILAB Use of an active ingredient derived from flax that acts on the papillary dermis, for its anti-ageing action
EP3744311A1 (en) * 2006-10-05 2020-12-02 Société Industrielle Limousine d'Application Biologique Dite SILAB Use of an active ingredient from flax acting on the papillary dermis, for anti-ageing action
FR2940610A1 (en) * 2008-12-30 2010-07-02 Oreal ASSOCIATION OF MONOSACCHARIDES WITH C-GLYCOSIDE DERIVATIVES AND ITS USE IN COSMETICS
US8445459B2 (en) 2008-12-30 2013-05-21 L'oreal Combination of monosaccharide with C-glycoside derivative and use thereof
US9364411B2 (en) 2008-12-30 2016-06-14 L'oreal Use of monosaccharides and composition therefor
EP2206491A1 (en) * 2008-12-30 2010-07-14 L'oreal Association of monosaccharides and C-glycoside derivatives and its use in cosmetics
EP2204162A1 (en) * 2008-12-30 2010-07-07 L'oreal Use of monosaccharides and composition

Also Published As

Publication number Publication date
FR2609397B1 (en) 1991-12-13

Similar Documents

Publication Publication Date Title
FR2609397A1 (en) Use of a substance or composition of carbohydrate nature as active principle of a dermatological and/or cosmetological and/or pharmaceutical and/or cell-stimulating composition, and composition containing such a substance or composition of carbohydrate nature
CH661205A5 (en) COSMETIC OR DERMATOLOGICAL COMPOSITIONS FOR SKIN CARE.
ES2209197T3 (en) USE OF GINSENOSIDE RB1 TO STIMULATE THE SYNTHESIS OF ELASTINE.
FR2980362A1 (en) NOVEL COSMETIC USE OF ALBIZIA JULIBRISSIN EXTRACT AND CORRESPONDING TOPICAL COMPOSITION
EP2882415A2 (en) Cosmetic or pharmaceutical moisturising ingredient
US11007136B2 (en) Cosmetic composition for wrinkle reduction containing gypenoside isolated from Gynostemma pentaphyllum
JP2003526646A (en) Use of plant extracts and sugars to protect keratinous tissue
WO1992009262A1 (en) Use of medicago saponins for the preparation of cosmetic or pharmaceutical compositions, dermatological compositions in particular, helping renew the epidermis, stimulating regrowth of hair, or delaying hair loss
KR101105816B1 (en) Method for the innoformulation of a biocompatible galenic base
WO1997006659A2 (en) Use of an eriobotrya japonica extract
KR20060136412A (en) Method for the innoformulation of a biocompatible galenic base
KR100338327B1 (en) External application for enhancing the skin permeability of the active components therein
WO1990006104A1 (en) Use of kaempferol and certain derivatives thereof for the preparation of a cosmetic or pharmaceutical composition
EP1530480B1 (en) Cosmetic composition comprising monosaccharides or polysaccharides, uses and treatment methods
KR102207561B1 (en) Natural cosmetic composition containing glycine soja(soybeen) seed extract
EP2874596B1 (en) Extract of cotton fibres and cosmetic composition and use thereof for protecting, nourishing and hydrating the skin
WO2004078789A1 (en) Novel agent for stimulating the release of beta-endorphins, cosmetic and/or dermatological compositions containing same and uses thereof
FR3110420A1 (en) PLANT COMPLEX BASED ON BETULINIC ACID AND AN AQUEOUS CHAGA EXTRACT AND APPLICATIONS IN COSMETICS
FR2735981A1 (en) COSMETIC OR PHARMACEUTICAL COMPOSITION CONTAINING A PLANT EXTRACT OF GENUS FOETIDIA
JP2003335619A (en) Skin care preparation for external use
JP2003335622A (en) Skin care preparation for external use
JP3235922B2 (en) Cosmetics
EP0835121A1 (en) COSMETIC OR PHARMACEUTICAL COMPOSITION CONTAINING AN EXTRACT OF PLANTS OF GENUS $i(FILICIUM), AND USE OF SAID EXTRACT FOR STIMULATING GLYCOSAMINOGLYCAN SYNTHESIS
FR3095345A1 (en) COSMETIC COMPOSITION INCLUDING A POLYMERIC MATRIX
EP2229145B1 (en) Use of a poppy petal extract for skin nutrition

Legal Events

Date Code Title Description
ST Notification of lapse